Fogliata Antonella, Clivio Alessandro, Nicolini Giorgia, Vanetti Eugenio, Cozzi Luca
Radiation Oncology Department, Medical Physics Unit, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
Radiother Oncol. 2007 Dec;85(3):346-54. doi: 10.1016/j.radonc.2007.10.006. Epub 2007 Oct 29.
A treatment planning study was performed to evaluate the performance of new radiotherapy techniques based on non-coplanar multiple fields or on dynamic conformal arcs for early stage breast treatments.
CT datasets of 7 different patients that were deemed unsuitable for tangential beam treatment due to a large volume of lung in the treatment fields were used as input for the study. Standard tangential field plans and inversely modulated IMRT plans were used as benchmark to evaluate performances of conformal plans with 3 non-coplanar fields (3F-NC), with 2 short dynamic conformal arcs (2-Arc) or hybrid plans with one static conformal field and one dynamic conformal arc (P-Arc). All plans were designed to achieve the higher target coverage and minimum ipsilateral lung involvement depending on the planning technique with a key objective to avoid involvement of the contralateral breast. The following planning objectives were selected. For PTV: D(1%) (maximum significant dose) lower than 110% and D(99%) (minimum significant dose) higher than 90%. For the ipsilateral lung a mean dose lower than 15 Gy and/or a volume receiving more than 20 Gy lower than 22%. For contralateral breast, all techniques but IMRT were set to have no beam impinging this organ at risk, while for IMRT plans were further designed to keep the mean dose lower than 5 Gy and to minimise the volume receiving a dose higher than 70% of the prescribed dose.
P-Arc resulted to be on average a better technique, as it provides a PTV dose distribution highly conformal (Conformity index 1.45), homogeneous (D(5%)-D(95%)=15.6%), with adequate coverage (V(90%)=96.4%) and a limited involvement of the ipsilateral lung (MLD approximately 9 Gy, V(5 Gy) approximately 36%, NTCP<2%) when compared to four other treatment techniques. 3F-NC presented similar but slightly worse performances on target: Conformity index 1.57, D(5%)-D(95%)=18.1%, V(90%)=95.7%). 3F-NC on ipsilateral lung resulted as the P-Arc. The tangential approach, the 2-Arc or the IMRT techniques, resulted to be inferior to the previous in either conformality (tangentials), ipsilateral lung sparing (tangentials, 2-Arc and IMRT) and in contralateral or healthy tissue involvement (IMRT).
For early stage breast cancer when high sparing of lung tissues is required and no involvement of contralateral breast is allowed, the P-Arc or the 3F-NC techniques might be recommended in terms of dosimetric expectations.
开展一项治疗计划研究,以评估基于非共面多野或动态适形弧的新放射治疗技术在早期乳腺癌治疗中的性能。
选取7例因治疗野内肺体积较大而被认为不适合切线野治疗的不同患者的CT数据集作为研究输入。使用标准切线野计划和逆向调制调强放疗计划作为基准,以评估具有3个非共面野(3F-NC)、2个短动态适形弧(2-Arc)的适形计划或具有一个静态适形野和一个动态适形弧的混合计划(P-Arc)的性能。根据规划技术,所有计划均设计为实现更高的靶区覆盖和最小的同侧肺累及,关键目标是避免对侧乳腺受累。选择了以下规划目标。对于计划靶体积(PTV):D(1%)(最大显著剂量)低于110%,D(99%)(最小显著剂量)高于90%。对于同侧肺,平均剂量低于15 Gy和/或接受超过20 Gy剂量的体积低于22%。对于对侧乳腺,除调强放疗外的所有技术均设置为无射线照射该危险器官,而对于调强放疗计划,则进一步设计为使平均剂量低于5 Gy,并尽量减少接受高于处方剂量70%的剂量的体积。
与其他四种治疗技术相比,P-Arc平均而言是一种更好的技术,因为它提供了高度适形的PTV剂量分布(适形指数1.45)、均匀性(D(5%)-D(95%)=15.6%)、足够的覆盖(V(90%)=96.4%)以及同侧肺的有限累及(平均肺剂量约9 Gy,V(5 Gy)约36%,正常组织并发症概率<2%)。3F-NC在靶区表现出相似但略差的性能:适形指数1.57,D(5%)-D(95%)=18.1%,V(90%)=95.7%)。3F-NC对同侧肺的影响与P-Arc相同。切线野方法、2-Arc或调强放疗技术在适形性(切线野)、同侧肺保护(切线野、2-Arc和调强放疗)以及对侧或健康组织累及(调强放疗)方面均不如前者。
对于需要高度保护肺组织且不允许对侧乳腺受累的早期乳腺癌,就剂量学预期而言,可能推荐P-Arc或3F-NC技术。